ENTITY
Daiichi Sankyo

Daiichi Sankyo (4568 JP)

140
Analysis
Health CareJapan
Daiichi Sankyo Co, Ltd is a holding company established through merger of Sankyo and Daiichi pharmaceutical. The Group manufactures pharmaceuticals for human/veterinary use and medical tools and equipment. It also researches and promotes products through related companies throughout the world. The Group also produces food, food additives, livestock feeds, and agrochemicals.
more
11 Apr 2019 12:09

🇯🇵 Japan • Relative Price Scores - Overbought & Oversold Companies - April 2019

- RELATIVE PRICE SCORE - INTRODUCTION - The Relative Price Score (RPS) is a measure of stock price performance relative to TOPIX calculated by...

Logo
723 Views
Share
18 Dec 2018 14:43

Japan Pharma - Top Picks

While Gni Group Ltd (2160 JP) is our high risk-high return pick, Mitsubishi Tanabe Pharma (4508 JP)  is a contrarian call in anticipation of value...

17 Dec 2018 08:01

Japan: Fortnightly Update - And So It Goes

AND SO IT GOES - After our eight-day 4.5% 'Thanksgiving rally', the market reverted to recent type and promptly fell 6.5% to Tuesday's low, which...

Logo
432 Views
Share
04 Nov 2018 17:10

Japan Fortnightly Update: Lower Low as Earnings Slow

LOWER LOW - Japanese equities reached a new 52-week low on 29th October but rebounded on the subsequent four trading days to close the...

Logo
381 Views
Share
bullishDaiichi Sankyo
31 Oct 2018 16:19

Daiichi Sankyo 1H FY18 (YE Mar'19) Results - First Glance

Key highlights Global Edoxaban sales increased ~64% y-o-y to ~¥52b, driven especially by brisk uptake in Japan (+53% to ~¥30b) and EU (+90% to...

x